[ad_1]
CNN has contacted Johnson & Johnson and the FDA for comment.
Even if the vaccine increases the risk of the syndrome, it is always better to be vaccinated against the coronavirus, the CDC pointed out.
“GBS is a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness or, in more severe cases, paralysis. Each year in the United States, approximately 3,000 to 6,000 people develop GBS; it is usually triggered by a respiratory problem or gastrointestinal infection. Most people fully recover from GBS, ”the CDC spokesperson said.
“Reports of GBS after receiving the J & J / Janssen COVID-19 vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but likely indicate a possible low risk of this side effect from this vaccine. About 100 preliminary reports of GBS were detected in VAERS after administration of 12.8 million doses of J & J / Janssen COVID-19 vaccine. These cases were widely reported around two weeks after vaccination and mainly in men, many of whom are in their 50s. years and older.
The same pattern is not observed with the other two vaccines authorized in the United States, manufactured by Moderna and Pfizer. The spokesperson said the CDC’s advisory committee on immunization practices would discuss the matter at a future meeting.
“In the United States, almost all hospitalizations and deaths related to COVID-19 now occur in unvaccinated people. The risk of serious adverse events after COVID-19 vaccination remains rare. It is recommended that anyone aged 12 and over receive a COVID-19 vaccine. “, says the press release.
The CDC and FDA briefly suspended use of the Johnson & Johnson vaccine earlier this year due to a risk of a rare blood clotting complication, but lifted the hiatus in April after determining the risk was low and that the disease was treatable. The vaccine label has been updated to warn of the risk.
[ad_2]
Source link